Alphabet Inc.'s Form 4 filing
Prime Medicine, Inc. (PRME) · filed May 24, 2023
- Accession no.
- 0001209191-23-031916
- Filed
- May 24, 2023, 5:07 PM ET
- Trade date
- May 22-23, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $1.89M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Alphabet Inc.CIK 0001652044 | 10% Owner |
| GV 2019 GP, L.L.C.CIK 0001845038 | 10% Owner |
| GV 2019 GP, L.P.CIK 0001845039 | 10% Owner |
| GV 2019, L.P.CIK 0001845041 | 10% Owner |
| GV 2021, L.P.CIK 0001861202 | 10% Owner |
| GV 2021 GP, L.L.C.CIK 0001861206 | 10% Owner |
| GV 2021 GP, L.P.CIK 0001861216 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 22, 2023 | Common Stock | JOtherDisposed | −87,922 | $0.00 | $0 | 10,557,092 | Indirect | |
| May 22, 2023 | Common Stock | SSaleDisposed | −87,922 | $14.13F4 | −$1,242,091.68 | 0 | Indirect | |
| May 23, 2023 | Common Stock | JOtherDisposed | −43,939 | $0.00 | $0 | 10,513,153 | Indirect | |
| May 23, 2023 | Common Stock | SSaleDisposed | −43,939 | $14.74F6 | −$647,647.68 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.335, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 4 and in footnote 6 of this Form 4.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.41 to $14.935, inclusive.
Referenced by the price of 1 transaction in Table I.